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Abstract
The notion of preconception care aims to target the existing risks before pregnancy, whereby resources may be
used to improve reproductive health and optimize knowledge before conceiving. The preconception period
provides an opportunity to intervene earlier to optimize the health of potential mothers (and fathers) and to
prevent harmful exposures from affecting the developing fetus. These interventions include birth spacing and
preventing teenage pregnancy, promotion of contraceptive use, optimization of weight and micronutrient status,
prevention and management of infectious diseases, and screening for and managing chronic conditions. Given
existing interventions and the need to organize services to optimize delivery of care in a logical and effective
manner, interventions are frequently co-packaged or bundled together. This paper highlights packages of
preconception interventions that can be combined and co-delivered to women through various delivery channels
and provides a logical framework for development of such packages in varying contexts.
Introduction
Given the extent of the burden of maternal, newborn and
child mortality; maternal, newborn and child health
(MNCH) interventions can be grouped together into pack-
age as part of continuum of care. This approach includes
integrated service delivery for mothers and children from
pregnancy to delivery, extending into the immediate post-
natal period, and childhood. The MNCH continuum of
care approach was introduced on the grounds that the
health and well-being of women, newborns, and children
are closely linked and should be managed in a unified way
[1]. Moreover, delivering interventions in the form of
packages promote greater efficiency by maximizing syner-
gies and avoiding duplication of services compared to
when delivered alone [2]. However, even with increased
prenatal and postnatal care practices, there was a slow
improvement in birth outcomes and this led to the realiza-
tion that prenatal care might be a step too late for preg-
nant mothers. Thus, the targeted MNCH momentum was
expanded to include reproductive health as an essential
component. The recent Lancet neonatal series reviewed
39 preconception and antenatal interventions, of which
only two were targeted interventions for the preconcep-
tion period [3]. The review further suggested six packages
along the continuum of care for 75 countdown countries
of which only one package included interventions for pre-
conception period [3]. The package included interventions
directed at improving nutritional status through balanced
energy protein supplementation, folic acid supplementa-
tion/fortification, and micronutrient supplementation.
Correcting nutritional status before pregnancy is impor-
tant but changing the dynamics of maternal, neonatal and
child health indices require holistic approach. Interven-
tions to prevent and treat infection, chronic diseases, men-
tal health and awareness of reproductive health are crucial
elements and should also be targeted before pregnancy for
ensuring improved pregnancy, neonatal and child health
outcomes.
Therefore, the notion of preconception care aims to tar-
get the existing risks before pregnancy, whereby resources
may be used to improve reproductive health of women,
men and couples in order to optimize health and knowl-
edge before conceiving a pregnancy. More recently, greater
attention is being paid to the period before pregnancy,
specifically focusing on preconception care. The precon-
ception period provides an opportunity to intervene earlier
to optimize the health of potential mothers (and fathers)
and to prevent harmful exposures from affecting the
developing foetus. These interventions include birth spa-
cing and prevention of teenage pregnancy as young
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a baby, leaving them and their children at risk for death or
disability from obstructed labor, fistulas, premature birth,
or low birth weight. At the same time, early childbearing
negatively affects educational and economic opportunities;
women with lower educational attainment have greater
risks of adverse pregnancy outcomes, are less knowledge-
able about health-prevention activities, and family plan-
ning. Their children have fewer options for education,
optimal growth and development and have a higher risk of
mortality.
Preconception care is the provision of biomedical, beha-
vioral and social health interventions to women and cou-
ples before conception occurs, aimed at improving their
health status, and reducing behaviours and individual and
environmental factors that could contribute to poor
maternal and child health outcomes [4]. Its ultimate aim is
improved maternal and child health outcomes, in both the
short and long term. For the purpose of this review,
preconception care and its boundaries were defined as:
“any preventive, promotive or curative health care inter-
vention provided to women of childbearing age in the
period before pregnancy (at least 2 years) or between con-
secutive pregnancies, to improve health related outcomes
for women (regardless of their pregnancy status), new-
borns or children up to 5 years of age” [5].
This paper summarizes key preconception risks and
interventions which impact maternal, fetal, neonatal and
child health outcomes (Refer to Paper 1-6), and proposes
packages of evidence-based effective interventions for
improved reproductive health and pregnancy outcomes.
The paper also proposes strategies for delivery for such
packages in varying contexts.
Proposed packages of care
We identified and recommended various interventions
through systematic reviews [6-11] and evidence synth-
esis that are summarized in Table 1 according to the
level of care at which each can be provided.
These interventions can also be bundled together and
delivered in various packages to increase efficiency and
give a synergistic effect. Figure 1 illustrates different
packages that can be delivered through various delivery
platforms. It is important to highlight that individual inter-
ventions included in these packages can be modified
according to local context, priorities as well as feasibility of
delivery within particular levels of the health and educa-
tion systems. To illustrate, these interventions can be
bundled into the following five packages for delivery.
1. Completion of secondary education for adolescent
girls and prevention of teenage pregnancy
2. Nutritional counselling and family planning
3. Nutritional optimization and weight loss programs
4. Multicomponent youth development programs
including infection prevention
5. Screening and management of chronic diseases
including mental health
1. Completion of secondary education for adolescent girls
and prevention of teenage pregnancy
To prevent teenage pregnancy and improve preconcep-
tion care this package proposes comprehensive counsel-
ling, education and life skills development. Published
papers highlighted the evidence regarding the adverse
effects of teenage pregnancy on maternal and neonatal
outcomes [12-15]. School-based prevention programs
underscored the importance of the intervention by
Table 1 Preconception interventions and their delivery according to the level of care
Interventions Level of care
Community Primary Referral
Promoting Reproductive health
Promoting adolescent health ✔ ✔
Preventing first and repeat pregnancy in adolescence ✔ ✔
Birth spacing ✔ ✔ ✔
Reproductive planning after abortion ✔
Advanced maternal age ✔ ✔
Genetic counselling ✔ ✔
Nutritional status and supplementation
Maternal pre-pregnancy weight ✔ ✔
Diet, exercise and weight loss ✔ ✔ ✔
Folic acid supplementation ✔ ✔
Multivitamins supplementation ✔ ✔
Iron supplementation ✔ ✔
Preventing and treating infections
Sexually transmitted infections ✔ ✔ ✔
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reducing psychological, physical and sexual dating vio-
lence [16-19], this was further confirmed in reviews
which reported multi component programs reduce the
assaults and incidence of domestic violence [7,20,21].
Considering these evidence, preconception counseling
should be made available especially in schools, commu-
nity centers, and adolescent health centers. These facil-
ities can provide a space where sexually active young men
and women know the risks of teen pregnancy, understand
the use of condoms as well as long-acting methods of
contraception. Sexual education appears to be more effec-
tive if it is integrated with broader life skills and education
programs, including vocational abilities, effective
communication, responsible decision making, proactive
approach to personal health care and an increased aware-
ness of health related issues. Since academic failure and
teenage pregnancies are seen to be so closely interlinked,
a special emphasis should be made to ensure that teenage
girls complete a basic secondary education which will
include educating young minds on preventing teenage
pregnancies. The purpose of education is to develop the
knowledge to observe, understand, reason and make
rational judgment about the known realities of the world
for optimum survival. Teens that have dropped out of
high school are more likely to become pregnant, and their
children are more likely to be deficient in terms of child
Table 1 Preconception interventions and their delivery according to the level of care (Continued)
HIV/AIDS prevention strategies ✔ ✔ ✔
Vaccine usage ✔ ✔ ✔
Periodontal disease and dental caries ✔ ✔
Cytomegalovirus ✔ ✔
Screening and management of chronic diseases
Diabetes ✔ ✔
Epilepsy management ✔
Management of Phenylketonuria ✔
Thyroid disorders ✔
Systemic Lupus Erythromatoses and other connective tissue diseases ✔
Medication use ✔ ✔
Mental health ✔ ✔
Intimate partner violence ✔ ✔
Substance abuse and lifestyle changes
Caffeine intake ✔ ✔
Alcohol intake ✔ ✔
Smoking cessation ✔ ✔
Illicit drugs consumption ✔ ✔
Ameliorating environmental exposures such as chemical and radiations ✔ ✔
Figure 1 Different packages of preconception care interventions
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development milestones such as language, communica-
tion, and cognition [22]. This has long-term implications
for them as individuals, their families and communities
[23]. Analysing the key issues in a community may help
to identify what or who are the major contributors; for
example service and health care providers may not be
offering adequate counselling, sexual health information
or contraceptive methods, or school systems may be defi-
cient in providing a comprehensive sexual health class or
may have failed to provide a safe environment where
teens may discuss their problems. In short, adolescent
sexual and reproductive health programs should include
counselling, reproductive planning and contraception,
and screening and management of sexually transmitted
infections (STIs). On the other hand, girls in marginalized
areas can be provided with preconception counseling in
community settings by community health workers and
outreach workers [7].
A teenager’s biggest asset is knowledge. Education is the
gradient process of acquiring knowledge. Knowledge gives
a teenager the tools for rational reasoning and judgment.
Knowledge helps a teen make better choices. Knowledge
gives you options. The more knowledge a teen has, the
more opportunities a teenager will have for making
money. It is, therefore, important to underscore the bene-
fits of completing secondary education among adolescents.
2. Family planning and nutrition counselling
Nutrition plays a paramount role in supporting the future
pregnancy. Nutritional counselling of women prior to con-
ception receives less importance compared to nutritional
counselling of pregnant women; however if family planning
and reproductive health services took a more integrated
approach and included nutritional counselling – this could
improve coverage. Preconception counselling will allow
women at higher risks of malnutrition, such as older
women (older than 35), teenage girls with restricted diets,
or malnourished women with vitamin deficiencies, to be
highlighted before conception so that appropriate action
may be taken. Adolescents typically consume a diet that
does not satisfy the required intake of iron, folate, or vita-
min B6 and have high chances of being anaemic. Thus an
integrated approach should be applied wherein couples
who come in for family planning services may be targeted
for nutrition counselling since they are at a preconception
stage where they are looking to plan a future family and
thus would want to adopt the best practices and habits to
do so. In low and middle income countries (LMICs) and in
marginalized parts of high income countries (HICs) where
food insecurity is an issue, community programs to grow
food or buy it collectively should be incorporated into
nutritional programs.
Pre-conception counselling There is evidence that pre-
conception counselling changes risk behaviours and
results in improved maternal and neonatal outcomes
[24-43]. This includes risk assessment and counselling of
women over the age of 35 on the increased risks asso-
ciated with advanced maternal age [44-83], as well as
genetic counselling of couples in a consanguineous mar-
riage to ensure a healthy fetal outcome [84-88]. A closer
look is taken into past obstetrical and gynecological his-
tory, past medical and drug history, chronic illnesses,
family history of genetic disease and psychosocial history
to rule out any potential complications of pregnancy.
However, further randomized controlled trials are needed
to show how preconception care affects maternal, new-
born and child health (MNCH) outcomes, and to delineate
where and by whom such care should be provided, how
long before conception such care should begin, and which
interventions are most successful.
Periconceptional folic acid supplementation Folic acid
supplementation is known to reduce the risk of neural
tube defects (NTDs) in the newborn [89-93]. Many
women are still unaware of how much their nutritional
status impacts their pregnancy outcomes, and improving
women’s nutritional behaviours should therefore begin
during their earlier reproductive years. Women wishing to
conceive should take 400ug of folic acid three months
prior to pregnancy [94]. Women who have previously
given birth to an infant with a NTD require higher levels
of folic acid supplementation (800μg). Providers should
assess women’s dietary habits and discuss the importance
of micronutrients as part of routine preconception coun-
seling. Other nutrition-specific interventions (iron,
calcium, balanced protein energy supplementation etc.)
have only been studied in pregnant women, or if they have
been studied during the preconception period the out-
comes are limited to changes in biochemical markers
while pregnancy and birth outcomes were not assessed
[95-100].
Family planning One of the reasons for the slow pro-
gress towards millennium development goal (MDG)-5 is
the inadequate delivery of family planning interventions,
resulting in unintended pregnancies, subsequent abortions,
and a subsequent rise in maternal mortality. A recent
report demonstrated a high unmet need for family plan-
ning in countries like Mali and Chad with the lowest con-
traceptive prevalence rates [101]. The evidence showed an
impact of long (>60 months) and short inter-pregnancy
intervals (IPIs) (<6 months) on preterm births, low birth
weight and small for gestational age babies [102-122]. The
evidence suggests that counselling can help women under-
stand the possible risks to themselves and their children of
very short and very long IPIs, and the risks of having an
unintended pregnancy and unsafe abortion [123]. Women
should be advised to wait 18-24 months after pregnancies
ending in a live birth, and at least 6 months after an abor-
tion, before conceiving again, and should be provided with
appropriate contraceptive counselling.
Lassi et al. Reproductive Health 2014, 11(Suppl 3):S7
http://www.reproductive-health-journal.com/content/11/S3/S7
Page 4 of 17
3. Nutritional optimization and obesity prevention and
management
Evidence has showed that pre-pregnancy underweight
and overweight are risk factors for an array of composite
adverse pregnancy and neonatal outcomes [63,124-155].
It is suggested that pre-pregnancy body mass index
(BMI) should be maintained within the normal range of
18.5–24.9 kg/m2 and controlled via diet and exercise
modifications (Refer to Paper 3[8]). The interventions
for healthy diet and exercise should be encouraged from
late childhood and early adolescent years to be effective
[156-166]. Routine preconception care with regards to
weight should include calculating BMI for women of
reproductive age, increasing awareness regarding the
risks associated with being overweight or underweight,
and helping women develop individualized dietary plans
including consumption of a variety of healthy foods in
appropriate amounts, and dietary supplements (espe-
cially a multivitamin containing 400 μg of folic acid, cal-
cium and vitamin D, and iron). Balanced protein energy
supplementation and appropriate micronutrient supple-
mentation can reduce the risk of outcomes related with
pre-pregnancy underweight, especially in LMICs. All
women should be encouraged to get their risks assessed
for cardiovascular health with regards to weight bearing
and offered appropriate lifestyle modifications. Women
with high BMI’s should be counselled to understand the
risks of infertility that are a part of increased weight gain.
A focus on screening, treating and preventing sexually
transmitted infections (STIs) in the preconception period
is vital, as well as educating parents about the risk of verti-
cal transmission of such infections to the child.
4. Multicomponent youth development programs including
prevention of sexually transmitted infections
Multicomponent youth development programs which
encompass social, family, peer, community, educational
and health disciplines are deigned to meet youth develop-
mental needs and help them become healthy, happy and
productive adults. Youth and particularly older children
should be encouraged to take part in these programs. A
proper and effective program will also help reduce pro-
blems such as substance abuse and teenage pregnancies
[167-169]. Mentoring will be an essential component of
these programs where developing youth are supported and
encouraged to develop competencies, to take on leadership
responsibilities, and to integrate into positive peer groups.
By focusing on health and self-confidence issues, guide-
lines on how to eat healthy and reach desired BMI, as well
as sexual health issues such as practicing safe sex and
when and how to deal with STIs may be included. Pro-
grams that deal with alcohol or substance abuse as well as
smoking cessation programs [29] can also be packaged
into these multicomponent youth development programs
to be highly effective [11].
Sexually Transmitted Infections The review of evidence
highlighted the wide gaps in current knowledge regarding
the effects of treatment of STIs in the preconception per-
iod on combined maternal and neonatal outcomes
[170-172]. Evidence from intervention that delivered beha-
vioural counselling showed reduction in re-infection and
new incidence of STI , thus this can reduce transmission
of infection to the newborn, as well as improve the health
of the woman during pregnancy and in the first year after
birth [173-175]. Preventive care can be implemented with
the application of preconception care by raising awareness
on STIs and their symptoms and prevention, cervical
screening, and PAP smears. All women of childbearing
age should undergo testing for STIs. It is, however, war-
ranted that more studies be conducted regarding STI
treatment and counselling in the preconception period on
maternal behaviours and future maternal and neonatal
outcomes [9].
HIV/AIDS prevention strategies All men and women
should be encouraged to find out their HIV status before
starting a family which can be a part of preconception
counseling; if women test positive, they should be edu-
cated in detail of the risks of vertical transmission to the
child and the risks for increased mortality and morbidity
that is associated with this disease. Various strategies (e.g.
prophylactic treatment of reproductive age women with
antiretrovirals to prevent HIV transmission to her partner
and newborn; condom use to prevent HIV transmission;
counseling and voluntary testing to lower the risk of trans-
mission through unprotected intercourse; and treatment
of STIs for risk reduction) for preventing HIV/AIDS were
reviewed [167,173,176-228]. Preconception care for
women living with HIV/AIDS or HIV-positive partners is
recommended. This should include effective and appropri-
ate contraception to reduce the chance of unintended
pregnancy, psychological and emotional support to encou-
rage disclosure of sero-status to partner, education regard-
ing the risks of perinatal transmission and strategies for
prevention and screening, and treatment for STIs in part-
ners [9].
5. Screening and management of chronic diseases including
mental health
The evidence highlights the importance of women’s
health status including the presence of chronic diseases,
current infections or syndromes, and promotes general
screening and management for other chronic health
related matters [229-264]. Another major component of
health, which is mental health, is also highlighted as a
package to reduce depression or anxiety disorders which
may have adverse effects on the child’s health [265,266].
On par with that, domestic violence will also have a nega-
tive impact on emotional health and mental wellbeing
such as posttraumatic stress disorder or psychiatric issues
with abuse or rape [267-315]. This package serves to
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highlight the importance of empowering women to take
control of their own health issues, to report physical or
sexual harassment and abuse, and to be proactive in mat-
ters concerning their own health by screening and testing
for chronic infections before planning a pregnancy
[10,316-328].
All women who are chronic carriers of a disease such
as hepatitis B should be counselled to receive vaccination
if not done previously and instructed on how to prevent
vertical transmission to future child or horizontal trans-
mission to close contacts. Women with chronic health
problems such as hypertension or hyper/hypothyroidism
should be counselled about the risks associated with their
disease during pregnancy, and the necessity to change
medication regimens while pregnant or conceiving to
optimize hormonal levels and to prevent any harm to the
foetus. Management and counselling of diabetic women
during the preconception period is more beneficial than
during pregnancy [329,330]. Preconception care for
women with pre-gestational diabetes should include edu-
cation about the importance of strict glycaemic controls
(with an HbA1C level of less than 6-7%) to prevent con-
genital anomalies; teaching self-management skills with
pre-set monitoring targets; counselling on the effect of
poor glycaemic control on maternal complications and
fetal complications; counselling about diet (as per proto-
col for diabetes); and healthy physical activity for weight
management [10]. Testing to detect pre-diabetes or type-
2 diabetes should be a priority for high-risk women who
are obese or overweight or those who have a strong
family history of diabetes.
Maternal Mental health Mental health issues in
mothers often remain undiagnosed and their management
often overlooked. Evidence suggests linkages between
poor adolescent mental health and poor pregnancy and
postpartum outcomes [10,331-334]. Preconception care
for psychiatric conditions is recommended; this should
include screening of women in their childbearing years for
mood disorders and identifying those at risk; counselling
women with pre-existing depression and anxiety disorders
about the potential risks of untreated illness and its asso-
ciated negative health outcomes; and informing potential
mothers about the risks and benefits of various treatment
options prior to conception and during pregnancy.
Women of reproductive age must be counselled that
relapse might be a complication during pregnancy for
bipolar disorder or schizophrenia patients since they will
be discontinuing treatment. A relapse prevention and
treatment strategy should be drawn out as part of a pre
conception plan.
Prevention of domestic violence Domestic violence in
females is a major contributor to ill health, particularly to
their reproductive and sexual health, and it is also a viola-
tion of human rights which is mostly brought about due
to gender inequality. A growing problem in both LMICs
and HICs, physical abuse leads to negative outcomes
such as injuries, trauma, unwanted pregnancies, and
emotional disturbances [270,281,288,295,296,335]. In
areas or societies where domestic violence is a common
practice, females might not have the autonomy of making
decisions related to their reproductive health which leads
to a higher risk of contracting sexually transmitted infec-
tions as well as unwanted pregnancies, or multiple preg-
nancies without adequate time to recover. Women who
are subject to regular acts of violence may be victims of
such abuse even during pregnancy, which has deleterious
effects on the foetus. General support groups may be
able to reduce incidences of domestic violence or at least
raise awareness among such females, and build a system
where such women can feel safe reporting such inci-
dences [10].
Opportunities for delivery
Interventions that are implemented in various settings
particularly in low-income countries face the challenge of
a lack of standardization across the line of service deliv-
ery, community outreach, and organizational policies.
Each setting has different requirements, which might
bring about healthcare inequities, but can be substantially
reduced by integrating intervention packages into exist-
ing local health programs. To ensure sustainability and to
be as efficient as possible at meeting health care out-
comes, the measure of integration with existing health
care systems and within other delivery platform is vital;
not only will it help in overcoming barriers to service
delivery and accessibility, but output delivery can be
amplified. As a result, existing systems are strengthened
and improved further, sparking positive development in
the form of viable healthcare networks in such commu-
nities. To ensure that the packages of care that have been
a product of much research and knowledge are translated
into action, the following opportunities for delivery and
integrating services within the broader platform can pro-
vide a means to do so.
a) Delivery within the education system
School health and reproductive health education programs
Information and services must be made available to ado-
lescents to educate them on their sexuality and protect
themselves from unwanted pregnancies, STIs, or risks of
infertility. School-wide accepted sexed programs have
shown to delay the onset of sexual activity and increase
safer sexual practices by those that are already sexually
active. All females should be counselled through regular
school health programs about eating disorders, such as
anorexia or bulimia and the risks to fertility and future
pregnancies it might have. The reproductive and sexual
health program should be integrated as a vital component
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of the school curricula and must be tested upon to empha-
size its importance. Adolescents should be guided as to
how to make responsible decisions concerning their sexual
lives, as well as how to practice safe sex, and how to pre-
vent unwanted pregnancies.
b) Delivery within health system
Primary-level health workers (e.g. community health
workers)
The primary level health workers are the backbone to the
whole establishment of primary health care. By delivering
health services to the doorsteps of the community as in
the case of community health workers (CHWs), concepts
such as family planning, vaccinations or immunizations,
proper growth monitoring, nutrition for neonates and
control of common diseases can be implemented. CHWs
can be trained to offer guidance and increase awareness
regarding STIs, to assess maternal health and nutrition
status in order to improve postpartum outcomes. They
can also provide information about all forms of contra-
ceptives, their benefits and efficacy and also provide
information on emergency contraception to the female
population of child bearing age in a community. Folic
acid, iron and micronutrient supplementations may also
be distributed in this way along with a basic orientation
of the importance of such supplements to improve
maternal and child health. Health education that is a vital
part of preconception care and health promotion, but
which may be impractical to distribute effectively in most
clinical settings, especially in busy health clinics with
large patient to doctor ratios can utilize CHWs to
increase awareness levels.
Pre-marital counseling and screening
Pre-marital counselling and screening allows couples to
test for the presence of infectious diseases such as HIV/
AIDS, Hepatitis B and C, syphilis or for genetic diseases
such as beta-thalassemia or sickle cell haemoglobinopa-
thies in both male and female to ensure proper care is
taken before a pregnancy is planned. Such services
should be available at all clinics/outreach clinics and doc-
tors should make patients aware that this is a necessary
and important step to take before starting a family. Regu-
lar screening should be conducted in high risk families
by testing them and having them sit down with a geneti-
cist and receive counselling on the best course of action.
This would greatly reduce the occurrence of hereditary
disorders.
Expanded post-natal care
During the first days to weeks after birth, the postnatal
period is the ideal time to deliver interventions to improve
the health and survival of both the newborn and the
mother, a facility that a majority of mothers currently
avail. However, an efficient strategy would be to expand
post-natal care to include preconception care as well to
optimize chances of a healthy conception, pregnancy and
delivery. Programs should also aim to provide earlier and
more integrated care as a majority of pregnancy complica-
tions may be avoided with proper screening, personal his-
tory, nutritional counseling, and genetic counseling so
parents can be better equipped to handle a pregnancy and
subsequent birth.
Take advantage of other health visits and missed
opportunities
For most patients coming in for regular check-ups to a
general physician in walk-in clinics, emergency depart-
ment and sports medicine clinics must take an accurate
and detailed history complete with relevant tests and refer
to a specialist when needed. The doctor can also offer
basic care and guidance regarding reproductive health to
patients to improve maternal, neonatal and child health.
Add preconception-related items to provider checklists
Integrate essential components of nutrition such as folic
acid, iron, zinc, and micronutrient supplementation along-
side programs that have a high coverage such as vaccina-
tion or immunization programs which could target both
pregnant women as well as neonates.
c) Other platforms
Community support groups
Community-based programs that provide pre-conception
services will cater directly to the specific needs of the
particular community. Instead of a larger scale system of
preconception care, support groups will be able to distri-
bute care into smaller communities, villages, and rural
areas. Members of support groups are usually facing
similar issues and can benefit greatly from the shared
experiences, advice and health support of the other parti-
cipants. Key issues of the community such as a high rate
of teenage pregnancies or poor family planning services
can also be targeted and interventions can then be tai-
lored and implemented accordingly. For example,
through support group sessions, teenage girls can be
taught confidence and empowerment skills to contest
early or forceful marriages; they can also be taught some
sort of self defence mechanism if rape and unwanted sex-
ual advances are an issue.
Mass media campaigns/ Social marketing
Modern marketing techniques and social communications
have been successfully used in many regions to promote
the importance of reproductive health. Many of the inter-
ventions can be delivered through health facilities but to
reach a larger audience mass mobile text messages or radio
announcements may also be used where applicable. Mass
campaigns regarding immunization programs in a locality
or on the importance of family planning and availability of
family planning clinics in different areas may be advertised
on TV channels, radio programs or through text messages.
Mass media campaigns for TV, radio and print media may
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be utilized to promote safer sexual practices, especially
using condoms to prevent STIs. Local celebrities or perso-
nas may be used to promote a healthy image of utilizing
pre-conception care at local health facilities. A challenge
faced by many at-risk young adults in developing countries
is the fact that most of them are illiterate, or have poor
exposure to educational programs – mass media may be a
very useful tool for effectively transmitting basic health
messages to such a population. It can also be an instru-
ment for changing behavioural stereotypes, pre-formed
attitudes, myths and misconceptions regarding reproduc-
tive health.
Workplace programs or referrals
Educational workshops may be conducted that are manda-
tory in workplace venues where men and women both
need to attend sessions on sexual health/STI’s, smoking
cessation, and other health-related topics. By providing
access to sexual rehabilitation programs for employees and
their spouses, which would include coping mechanisms for
infertility, menopause, late pregnancies, miscarriages, or
pregnancy complications, a significant reduction in risky
sexual behaviors and practices as well as distress resulting
from infertility or other issues may be achieved. A high pre-
valence of sexual problems with age may be secondary to
other medical conditions which must be investigated; when
left untreated, these problems will lead to a decreased qual-
ity of life, depression, peer and spouse conflicts.
Food fortification
Food fortification is the practice of adding micronutrients to
processed foods for an increase in the micronutrient status
of a population and a decrease in deficiencies and related
programs. A very cost-effective program, the addition of
folic acid to enrich flour, rice and pasta takes advantage of
existing technologies and local distribution networks.
Support groups for individuals with a particular risk
Support groups for high-risk couples and women, includ-
ing those who have experienced a previous poor outcome.
Such programs provide outreach, case management, risk
reduction, support, prenatal/preconception care, health
education and community development to high-risk
women and couples. Such women and couples who have
had a previous miscarriage, delivery of a low birth weight
(LBW) infant, lack of family planning, repeated STI’s, early
pregnancies, substance abuse, and lack of access to repro-
ductive health care would be the target group for maxi-
mum benefit. The individual’s case would be assessed and
a goal plan drawn out involving the patient at every step;
from here on, the support group staff ensures compliance
with services and keeps updated with the achievement of
personal goals.
Discussion
This paper has highlighted the inextricable link between
maternal and newborn health by providing evidence of
the effect of interventions delivered during the precon-
ception period on maternal and neonatal outcomes.
Only a few systematic efforts have identified potential
synergies between key reproductive health interventions
on maternal and perinatal outcomes. This paper identi-
fied papers that underscored these synergies and illu-
strated a number of important interventions that should
be delivered during the preconception period. Most of
the interventions reviewed will require additional high
quality evidence before recommendation for their imple-
mentation in programs.
Considering the interdependent relationship between
maternal and neonatal health, approaching interventions
that have a direct effect on MNCH services has great
potential for accelerating progress towards MDG 4 and 5.
The integration of these interventions needs to span not
only in time period (pregnancy, childbirth, and the postna-
tal period) but also levels of care (household, community,
and health facilities). The delivery of these interventions
can have profound translational and intergenerational
impacts with important implications for the long-term
well-being of both mother and newborn. This can also
promote greater efficiency by maximizing synergies and
avoiding duplication of services that are less efficient if
delivered individually. Therefore, these interventions
should be integrated in health policies and programs. Such
potential integration of strategies would not only help
improve maternal and newborn outcomes but would also
save scarce resources. This approach is critical to achiev-
ing MDGs 4 and 5 and making sure that we progress
beyond saving lives to also improving morbidities and
other developmental outcomes.
At the present time, preconception care is not imple-
mented at a global level, and is not a widespread concept
in LMICs as of yet. These packages feature intervention
packages, opportunities for delivery and highlight the
implementation of intervention packages via existing
health care and public health programs. An emphasis is
placed on the importance of expanding already existing
programs such as antenatal care to include preconception
care which would be an effective strategy in low-income
countries and would capture a wide audience. To imple-
ment on a community level, an understanding and aware-
ness should be developed for all stakeholders so that
healthcare providers as well as higher policy makers may
reach a shared consensus. A shared goal and a quantifiable
and easily measured objective must be drawn out such as
a reduction in maternal and infant mortality by a predeter-
mined date in time or a significant decrease in maternal
and neonatal infections for example. Organizations who
propose to forward the preconception care packages and
health care providers, as well as primary level health care
workers such as community health workers should
develop an agenda for goals, objectives, action plans, and
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evaluation strategies. Those organizations that have prior
experience in delivering preconception care could be
invited to give an expert opinion in what approaches are
effective or what errors may be avoided.
Since malnutrition and vitamin and nutrient deficiencies
contribute globally to a huge burden of disease processes,
from LMICs to HICs, packages focused on supplementation
strategies such as folic acid or micronutrient supplementa-
tion, and fortification of foods should be implemented on a
national level with strict guidelines and limitations. Iodine,
iron, vitamin A, and zinc were identified being among the
world’s most serious health risk factors leading not only to
clinical manifestations such as anaemia or metabolism dis-
orders but also contributing to delayed motor and cognitive
development. Food fortification, when implemented on a
national level, with effective policies to govern safe practices,
will be able to target a large segment of the population. In
countries where vitamin D levels has been tested and
known to be deficient in over 90% of the population, vita-
min D fortified milk should be made available at all places.
Where the level of deficiencies are too high such as popula-
tions where anaemia rates are endemic, then accessibility of
the fortified foods to poorer settlements must be taken into
concern or the presence of existing infections must be eval-
uated since it will raise the metabolic requirement for the
micronutrient.
Multi-component youth development programs, sexual
education programs, and community support groups as
packages should be targeted to empower women and girls
to take control of their own health especially reproductive
health, to make responsible and autonomous decisions
regarding their sexual life, to prevent or report domestic
violence, and to prevent sexually transmitted infections by
being firm on the use of contraceptives. This can be
implemented at the community level with regards to spe-
cific issues of each community such as a high rate of rape
cases may be countered with increased awareness and
availability of emergency contraception and promotion of
self –defence.
Other packages such as nutritional counselling, genetic
counselling, and pre-marital screening should be targeted
to involve both male and females as a couple and the
focus should be on the health and wellbeing of the future
family including parents and the child. Other packages
such as family planning or contraceptive methods should
take a multi-centred approach with delivery through var-
ious forums such as awareness through workshops and
community support groups, provision of subsidized con-
doms in a poor community, advocating the benefits and
warning of the risks of infections through health care
facilities.
For implementation in LMICs at a community and
facility level, cultural and social diversities and customs
must be taken into account. Many regions and areas
have deeply embedded social norms and traditions that
govern their people’s beliefs and actions; an example
would be of religious barriers to contraceptive methods
practiced in a majority of rural or low income commu-
nities especially in South East Asia. This would provide
a significant barrier to preconception care packages
such as family planning packages, which rely on effective
contraceptive practices, or packages that advocate the
use of condoms to prevent STIs. CHWs can be directed
to raise awareness levels in such communities while
delivering packages as doorsteps as well as conducting
community level workshops.
Once a shared consensus of the aims and objectives are
drawn out, all stakeholders must be engaged from the
community to the national level; those organizations such
as non-profit organizations which are working on a sole
purpose such as reducing HIV/AIDS prevalence may be
incorporated into this wider program and be used to reach
a larger target audience. Rehabilitation centres for sub-
stance abuse, smoking cessation clinics, and other outlets
may be utilized as well to bring about a combined precon-
ception package to a much larger segment of the popula-
tion. Areas where these packages may not be reaching
such as prisons or homeless shelters for example must
have a specified implementation package as well to ensure
as large a distribution of preconception care as possible.
Conclusion
Since reducing maternal and child mortality and morbidity
rates are of utmost and urgent concern in LMICs and
more specifically in certain regions in these countries, then
preconception care can address such populations with the
appropriate packages of care. To achieve that significant
reduction in maternal and child mortality rates, existing
care that includes pregnancy care, as well as antenatal care
should be extended to include preconception care as well
as take into account adolescents, women of child-bearing
age, and all high risk women. A focus on prevention of
infections or deleterious habits, which will eventually
become complications during pregnancy and a primary
focus on improving reproductive health, will be the corner-
stones of the implementations of these packages.
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